Asia-Pacific Lyophilized Injectable Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type of Packaging (Single-Use Vials, Point-of-Care Reconstitution, and Specialty Packaging), Type of Delivery (Prefilled Diluent Syringes, Single-Step Devices, Proprietary Reconstitution Devices, and Multi-Step Devices), Indication (Metabolic and Oncology Conditions, Infectious Diseases, Autoimmune Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others)   

No. of Pages: 141    |    Report Code: BMIRE00027577    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia-Pacific Lyophilized Injectable Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia-Pacific Lyophilized Injectable Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia-Pacific Lyophilized Injectable Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in biologics and injectable drug treatments
  • 5.1.2 Growth in demand for lyophilized injectable drugs
5.2 Market Opportunities
  • 5.2.1 Expansion in biologics and biotechnology industries
  • 5.2.2 Growth in demand for lyophilized injectable drugs in advanced therapies
5.3 Future Trends
  • 5.3.1 Growth in focus on freeze-dried drugs and biologics
  • 5.3.2 Rising demand for lyophilized drugs in oncology and critical care treatments
5.4 Impact of Drivers and Restraints

6. Asia-Pacific Lyophilized Injectable Market Regional Analysis

6.1 Asia-Pacific Lyophilized Injectable Market Overview
6.2 Asia-Pacific Lyophilized Injectable Market Revenue 2020-2028 (US$ Million)
6.3 Asia-Pacific Lyophilized Injectable Market Forecast Analysis

7. Asia-Pacific Lyophilized Injectable Market Analysis – by Type of Packaging

7.1 Single-Use Vials
  • 7.1.1 Overview
  • 7.1.2 Single-Use Vials: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Point-of-Care Reconstitution
  • 7.2.1 Overview
  • 7.2.2 Point-of-Care Reconstitution: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Specialty Packaging
  • 7.3.1 Overview
  • 7.3.2 Specialty Packaging: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia-Pacific Lyophilized Injectable Market Analysis – by Type of Delivery

8.1 Prefilled Diluent Syringes
  • 8.1.1 Overview
  • 8.1.2 Prefilled Diluent Syringes: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Single-Step Devices
  • 8.2.1 Overview
  • 8.2.2 Single-Step Devices: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Proprietary Reconstitution Devices
  • 8.3.1 Overview
  • 8.3.2 Proprietary Reconstitution Devices: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Multi-Step Devices
  • 8.4.1 Overview
  • 8.4.2 Multi-Step Devices: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia-Pacific Lyophilized Injectable Market Analysis – by Indication

9.1 Metabolic and Oncology Conditions
  • 9.1.1 Overview
  • 9.1.2 Multi-Step Devices: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Infectious Diseases
  • 9.2.1 Overview
  • 9.2.2 Multi-Step Devices: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Autoimmune Diseases
  • 9.3.1 Overview
  • 9.3.2 Multi-Step Devices: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia-Pacific Lyophilized Injectable Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia-Pacific Lyophilized Injectable Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 China: Asia-Pacific Lyophilized Injectable Market Breakdown, by Type of Packaging
    • 10.1.1.1.2 China: Asia-Pacific Lyophilized Injectable Market Breakdown, by Type of Delivery
    • 10.1.1.1.3 China: Asia-Pacific Lyophilized Injectable Market Breakdown, by Indication
  • 10.1.1.2 India: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 India: Asia-Pacific Lyophilized Injectable Market Breakdown, by Type of Packaging
    • 10.1.1.2.2 India: Asia-Pacific Lyophilized Injectable Market Breakdown, by Type of Delivery
    • 10.1.1.2.3 India: Asia-Pacific Lyophilized Injectable Market Breakdown, by Indication
  • 10.1.1.3 Japan: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Japan: Asia-Pacific Lyophilized Injectable Market Breakdown, by Type of Packaging
    • 10.1.1.3.2 Japan: Asia-Pacific Lyophilized Injectable Market Breakdown, by Type of Delivery
    • 10.1.1.3.3 Japan: Asia-Pacific Lyophilized Injectable Market Breakdown, by Indication
  • 10.1.1.4 Australia: Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Australia: Asia-Pacific Lyophilized Injectable Market Breakdown, by Type of Packaging
    • 10.1.1.4.2 Australia: Asia-Pacific Lyophilized Injectable Market Breakdown, by Type of Delivery
    • 10.1.1.4.3 Australia: Asia-Pacific Lyophilized Injectable Market Breakdown, by Indication
  • 10.1.1.5 Rest of Asia-Pacific : Asia-Pacific Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia-Pacific Lyophilized Injectable Market Breakdown, by Type of Packaging
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia-Pacific Lyophilized Injectable Market Breakdown, by Type of Delivery
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia-Pacific Lyophilized Injectable Market Breakdown, by Indication

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia-Pacific Lyophilized Injectable Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Aristopharma Ltd.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Baxter
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 CordenPharma International
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Credence MedSystems, Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Curia Global, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Jubilant HollisterStier (Jubilant Pharma Limited)
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Nipro
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Recipharm AB
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 S.G. Biopharm Pvt. Ltd.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Vetter Pharma
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - Asia-Pacific Lyophilized Injectable Market

  1. Aristopharma Ltd.
  2. Baxter
  3. CordenPharma International
  4. Credence MedSystems, Inc.
  5. Curia Global, Inc.
  6. Jubilant HollisterStier (Jubilant Pharma Limited)
  7. Nipro
  8. Recipharm AB
  9. S.G. Biopharm Pvt. Ltd.
  10. Vetter Pharma      
asia-pacific-lyophilized-injectable-market